We Are Committed To Effective Therapeutic Outcomes For All
Dedicated to developing therapeutics that are prevalent in under-represented patient populations.
Our Division’s Mission Is to Support Therapeutic Access for Effective and Inclusive Outcomes.
Diving deep into enormous data sets, we’re centrally focused on creating the therapies broad communities are needing.
Disease Target Areas
Neglected Tropical Diseases
Rubix’s pipeline promises to improve patients’ outcomes and support the healthcare systems by enabling access to better care for underrepresented patients. The lead candidate, Project Hercules, is a proprietary first-line combination product targeting Osteonecrosis and similar orthopedic diseases.
Project Icarus is developed for the targeted therapy for brain cancer and tumors, such as DIPG for pediatric cases and GBM.
In addition, Rubix LS continues to expand its strong product pipeline with other products in preclinical development.
Our Clinical Trials
Your Health Starts Here
For patients, researchers, and external stakeholders find more information by clicking the button below.